Keywords: Takeda, Amgen, Vectibix, Rozerem, Nesina, Metact, Unisia

Japan’s Takeda gets five new products approved on home market, and partner Amgen reveals strong results with Vectibix

Article | 19 April 2010

Print This

It was a good news day last Friday for Japan’s biggest drugmaker, Takeda Pharmaceutical, which announced that New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in